Pathways unique to the BPH versus PCa model were dominated by platelet activation and the related molecular signaling pathway that triggers this event, Ras/Raf/mitogen-activated protein kinase (MAPK) cascades. This evidence concerns the gene WNK2 and benign prostatic hyperplasia.